Results 301 to 310 of about 869,733 (343)
Megakaryocyte phenotyping in response to SARS-CoV-2 variants. [PDF]
Sowa MA+6 more
europepmc +1 more source
ABSTRACT Anticipating the evolution of septic patients with community‐acquired pneumonia (CAP) is challenging for front‐line physicians in the Emergency Department (ED). Prognosis depends mainly on early identification, antibiotics, organ support, but also immune status.
Thomas Lafon+4 more
wiley +1 more source
Evaluation of the cobas SARS-CoV-2 & Influenza A/B v2 assay for detecting SARS-CoV-2 and influenza A and B viruses in nasopharyngeal swab specimens. [PDF]
Jeong E+9 more
europepmc +1 more source
We developed a nanopore array strategy based on nanoparticle blockage for rapid detection and quantification of ultralow‐concentration nanoparticles. Using hydraulic force, nanoparticles are driven through an array of pores smaller than the nanoparticles, and optical microscopy tracks blockage progression to obtain quantitative concentration ...
Rami Yazbeck+6 more
wiley +1 more source
Detection of SARS-CoV-2 in Settings Including Point-of-Care: Performance of the Cobas SARS-CoV-2 NAT and Utility with the Cobas Liat System. [PDF]
Bolanaki M+6 more
europepmc +1 more source
The graphical abstract shows the various phenomena the droplet undergo during evaporation, precipitation, and transfer to susceptible host. Abstract This study investigates how pathogen‐laden respiratory droplets transfer diseases via inanimate surfaces.
Abdur Rasheed+5 more
wiley +1 more source
Aggregation potency and proinflammatory effects of SARS-CoV-2 proteins. [PDF]
Costa M+7 more
europepmc +1 more source
Exploring the oncogenic potential of SARS-CoV-2 in the gastrointestinal tract. [PDF]
Miteva DG+3 more
europepmc +1 more source